Clinical trials: Cysticercosis
Neurocysticercosis, Epilepsy
Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
The purpose of this study is to determine if combination drug therapy of praziquantel and albendazole is safe and effective to cure neurocysticercosis.
- Trial name
- NCT00441285
- Testing
- Praziquantel, Albendazole
- Where
- 5 sites in Peru
- Volunteers
- 156 people
- Sponsor
- Universidad Peruana Cayetano Heredia